Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-19T01:20:51.463Z Has data issue: false hasContentIssue false

6 - Alcoholic Liver Disease

Published online by Cambridge University Press:  08 August 2009

Zobair M. Younossi
Affiliation:
Inova Fairfax Hospital, Annandale, VA
Get access

Summary

INTRODUCTION

Alcohol is a socially accepted hepatotoxin and its abuse costs approximately $200 billion annually. In the U.S. population, 7–10% meets the diagnostic criteria for alcohol abuse or alcoholism. Alcohol accounts for 40–50% of all the deaths due to cirrhosis and remains the most common cause of liver-related mortality. However, alcoholic liver disease (ALD) represents a spectrum of histologic changes as shown in Table 6.1 with different clinical outcomes.

The mortality rate of alcoholic fatty liver is insignificant, while the age adjusted death rate for alcoholic cirrhosis is 3.8 per 100,000. The five- and 10-year survival rates for alcoholic cirrhosis without liver transplantation are 23% and 7%, respectively, which is significantly less than other forms of cirrhosis (see Table 6.2).

RISK FACTORS

However, it has been estimated that although 75–100% of heavy drinkers show evidence of fatty liver, only 8–20% of patients will develop cirrhosis. Therefore, other factors must play a role in placing these individuals at risk for developing more severe forms of ALD. A number of risk factors have been proposed as shown in Figure 6.1, but none of them can either singly or in combination completely explain the reason why only a minority of individuals ingesting large amounts of alcohol develop ALD.

Quantity of Alcohol Ingested

The quantity of alcohol ingested is the most important risk factor (Table 6.3). Although most investigators agree that those who drink heavily (4–5 drinks per day) are at risk for ALD, others.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Dawson, DA, Grant, BF, Chou, SP, Pickering, RP. Subgroup variation in the U.S. drinking patterns: Results of the 1992 National Longitudinal Alcohol Epidemiologic Study. J Subst Abuse 1995;7:331–4.CrossRefGoogle ScholarPubMed
Jamal MM, Mandavam S., Morgan, TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004;24:217–32.Google Scholar
Jamal, MM, Morgan, TR. Liver disease in alcohol and hepatitis C. Best Pract Res Clin Gastroenterol 2003;17:649–62.CrossRefGoogle ScholarPubMed
O'Shea, RS, McCullough, AJ. Treatment of alcoholic hepatitis. Clin Liver Dis 2005;9:103–34.CrossRefGoogle ScholarPubMed
Dam-Larsen, S, Franzmann, M, Andersen, IB, Christoffersen, P, et al. Long-term prognosis of fatty liver: Risk of chronic liver disease and death. Gut 2004;53:750–5.CrossRefGoogle ScholarPubMed
Singh, GK, Hoyert, DL. Social epidemiology of chronic liver disease and cirrhosis mortality in the United States 1935–1977: Trends and differentials by ethnicity, socioeconomic status and alcohol consumption. Hum Biol 2000;72:801–20.Google Scholar
Bellentani, S, Saccoccio, G, Costa, G, Tiribelli, C, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845–50.CrossRefGoogle ScholarPubMed
Kamper-Jorgensen, M, Gronbaek, M, Tolstrup, J, Becker, U. Alcohol and cirrhosis: dose-response or threshold effect?J Hepatol 2004;41:25–30.CrossRefGoogle ScholarPubMed
Becker, U, Gronbaek, M, Johansen, D, Sorensen, TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002;35:868–75.CrossRefGoogle ScholarPubMed
Barrio, E, Tome, S, Rodriguez, I, Gude, F, et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin Exp Res 2004;28:131–36.CrossRefGoogle ScholarPubMed
Tolstrup, JS, Jensen, MK, Tjonneland, A, Overvad, K, Gronback, M. Drinking pattern and mortality in middle-aged men and women. Addiction 2004;99:323–30.CrossRefGoogle ScholarPubMed
Lu, XL, Luo, JY, Tao, M, Gen, Y, Zhao, P, et al. Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004;10:2423–6.CrossRefGoogle Scholar
French, SW. The role of hypoxia in the pathogenesis of alcoholic liver disease. Hepatol Res 2004;29:69–74.CrossRefGoogle ScholarPubMed
Mansouri, A, Gaou, I, DeKerguenec, C, Amsellem, S, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999;117:181–90.CrossRefGoogle ScholarPubMed
Loft, S, Olesen, KL, Dossing, M. Increased susceptibility to liver disease in relation to alcohol consumption in women. Scand J Gastroenterol 1987;22:1251–6.CrossRefGoogle ScholarPubMed
Becker, U, Deis, A, Sorensen, TI, Gronbaek, M, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology 1996;23: 1025–9.CrossRefGoogle ScholarPubMed
Lelbach, WK. Epidemiology of alcoholic liver disease. Prog Liv Dis 1976;5:494–515.Google ScholarPubMed
Crabb, DW. Pathogenesis of alcoholic liver disease: Newer mechanisms of injury. Keio J Med 1999;48:184–8.CrossRefGoogle ScholarPubMed
Poynard, T, Bedossa, P, Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancer 1997;349:825–32.CrossRefGoogle ScholarPubMed
Bellentani, S, Pozzato, G, Saccoccio, G, Crovatto, M, Croce, LS, et al. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: Report from the Dionysos study. Gut 1999;44:874–80.CrossRefGoogle ScholarPubMed
Corrao, G, Arico, S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998;27:914–19.CrossRefGoogle ScholarPubMed
Hezode, C, Lonjon, I, Roudot-Thoraval, F, Pawlotsky, JM, Safrani, ES, Shumeaux, D. Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study. Aliment Pharmacol Ther 2003;17:1031–7.CrossRefGoogle ScholarPubMed
Monto, A, Patel, K, Bostrom, A, Pianko, S, et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 2004;39:826–34.CrossRefGoogle ScholarPubMed
Freeman, AJ, Dore, GJ, Law, MG, Thorpe, M, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001 Oct;34(4 Pt1):809–16.CrossRefGoogle Scholar
Hutchinson, SJ, Bird, SM, Goldberg, DJ. Influence of alcohol on the progression of hepatitis C virus infection: A meta-analysis. Clin Gastroenterol Hepatol 2005;3(11): 1150–9.CrossRefGoogle Scholar
Tsui, JI, Pletcher, MJ, Vittinghoff, E, Seal, K, Gonzales, R. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006;44: 262–6.CrossRefGoogle ScholarPubMed
Yokoyama, H. Ishii H, Moriya, S, Magata, S, Watanabe, T, Kamegaya, K, et al. Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol 1995;22:130–4.CrossRefGoogle ScholarPubMed
Fasani, P, Sangiovanni, A, DeFazio, C, Borzio, M, Bruno, S, Ronchi, G, et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 1999;29:1704–7.CrossRefGoogle ScholarPubMed
Marsano, LS, Pena, LR. The interaction of alcoholic liver disease and hepatitis C. Hepatogastroenterology 1998;45:331–9.Google ScholarPubMed
Monto, A, Wright, TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001;28:441–9.CrossRefGoogle ScholarPubMed
Sarin, SK, Dhingra, N, Bansal, A, Malhotra, S, Guptan, RC. Dietary and nutritional abnormalities in alcoholic liver disease: A comparison with chronic alcoholics without liver disease. Am J Gastroenterol 1997;92:777–83.Google ScholarPubMed
Leevy, CM, Moroianu, SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005;9:67–81.CrossRefGoogle ScholarPubMed
Iturriaga, H, Bunont, D, Hirsch, S, Ugarte, G. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutri 1988;47:235–8.CrossRefGoogle ScholarPubMed
Naveau, S, Giraud, V, Borotto, E, Aubent, A, Capron, F, Chaput, JC. Excess weight as a risk factor for alcoholic liver disease. Hepatology 1997;25:108–11.CrossRefGoogle ScholarPubMed
Lu, XL, Luo, JY, Tao, M, Gen, Y, Zhao, P, Zhao, HL. Risk factors for alcoholic liver disease in China. World J Gastroenterol 2004;10:2433–66.CrossRefGoogle Scholar
Mezey, E. Dietary fat and alcoholic liver disease. Hepatology 1998;28:901–9.CrossRefGoogle ScholarPubMed
Mathurin, P, Is alcoholic hepatitis an indicator for transplantation? Current management and outcomes. Liver Transplantation 2005;11(suppl 1): 21–4.CrossRefGoogle Scholar
Kurner, T, Kropf, J, Kosche, R, Kristal, H, Jaspersen, D, Gressner, AM. Improvement of prognostic power of the Child-Pugh classification of liver cirrhosis by hyaluronan. J Hepatol 2003;39:947–53.CrossRefGoogle Scholar
Orrego, H, Israel, Y, Blake, JE, Medline, A. Assessment of prognostic factors in alcoholic liver disease toward a global quantitative expression of severity. Hepatology 1983;3:896–905.CrossRefGoogle Scholar
Maddrey, WC. Alcoholic hepatitis: Clinicopathologic features and therapy. Semin Liv Dis 1988;8:91–102.CrossRefGoogle ScholarPubMed
Mathurin, P, Duchatelle, V, Ramond, MJ, Degott, C, Bedossa, P, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847–53.CrossRefGoogle ScholarPubMed
Sheth, M, Riggs, M, Patel, T. Utility of the Mayo end-stage liver disease. MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:1–5.CrossRefGoogle ScholarPubMed
Thabut, D, Navean, S, Charlotte, F, Massard, J, et al. The diagnostic value of biomarkers. Ash test) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol 2006;44:1175–85.CrossRefGoogle Scholar
Mendenhall, CK. Alcoholic hepatitis. In: SchiffL, L,Schiff, ER, editors. Diseases of the liver. 6th edition. Philadelphia: JB Lippincott Co, 1987, pp. 669–685.Google Scholar
Srikureja, W, Kyola, NL, Runyon, R, Hu, KQ. Meld score is a better prognostic model than Child-Turcotte-Pugh score on discriminant function score in patients with alcoholic hepatitis. J Hepatol 2005;42:700–6.CrossRefGoogle ScholarPubMed
Mathurin, P, Abdelnour, M, Ramond, MJ, Carbonell, N, Fartoux, L, et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003;38:1363–9.CrossRefGoogle ScholarPubMed
Helman, RA, Temko, MH, Nye, SW, Fallon, HU. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311–21.CrossRefGoogle ScholarPubMed
Porter, HP, Simon, FR, Pope, CE, Volwiler, W, Fenster, LF. Corticosteroid therapy in severe alcoholic hepatitis. N Engl J Med 1971;284:1350–5.CrossRefGoogle ScholarPubMed
Campra, JL, Hamlin, EM Jr, Kirshbaum, RJ, Olivier, M, Redeker, AG, Reynolds, TB. Prednisone therapy of acute alcoholic hepatitis. Ann Intern Med 1973;79:625–31.CrossRefGoogle ScholarPubMed
Blitzer, BL, Mutchnick, MG, Joshi, PH, Phillips, MM, Fessel, JM, Conn, HO. Adrenocorticosteroid therapy in alcoholic hepatitis: A prospective, double-blind randomized study. Am J Dig Dis 1977;22:477–84.CrossRefGoogle ScholarPubMed
Lesesne, HR, Bozymski, EM, Fallon, JH. Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements. Gastroenterology 1978;74:169–73.Google ScholarPubMed
Maddrey, WC, Boitnott, JK, Bedine, MS, Weber, FL Jr, Mezey, E, White, RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193–9.Google ScholarPubMed
Shumaker, JB, Resnick, RH, Galambos, JT, Makopour, H, Iber, FL. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. Am J Gastroenterol 1978;69:443–9.Google ScholarPubMed
Depew, W, Boyer, T, Omata, M, Redeker, A, Reynolds, T. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy. Gastroenterology 1980;78:524–9.Google ScholarPubMed
Theodossi, A, Eddleston, ALWF, Williams, R. Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis. Gut 1982;23:75–9.CrossRefGoogle ScholarPubMed
Mendenhall, CL, Anderson, S, Garcia-Pont, P, Goldberg, S, et all. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984;311:1464–70.CrossRefGoogle ScholarPubMed
Bories, P, Guedj, JY, Mirouze, D, Yousfi, A, Michel, H. Traitement de L'hépatite alcoolique aiguë par la prednisolone. Presse Med 1987;16:769–72.Google Scholar
Carithers, RL Jr, Herlong, HF, Diehl, AM, Shaw, EW, Combes, B, Fallon, HJ, Maddrey, WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trialAnn Intern Med 1989;11:685–90.CrossRefGoogle Scholar
Ramond, MJ, Poynard, T, Rueff, B, Mathurin, P, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507–12.CrossRefGoogle ScholarPubMed
Daures, JP, Peray, P, Bories, P, Blanc, P, Yousfi, A, Michel, H, Gremy, F. Place de la corticotherapyie dans le traitement des hépatite alcoolique aiguë. Resultats dune métaanalyse. Gastroenterol Clin Biol 1991;15:223–28.Google Scholar
Reynolds, TB, Benhamou, JP, Blake, J. Treatment of alcoholic hepatitis. Gastroenterol Int 1989;2:208–16.Google Scholar
Imperiale, TF, McCullough, AJ. Do corticosteroids reduce mortality from alcoholic hepatitis. Ann Intern Med 1990;113:299–307.CrossRefGoogle ScholarPubMed
Mathurin, P, Mendenhall, CL, Carithers, RL Jr, Ramond, MJ, et al. Corticosteroids improve short term survival in patients with severe alcoholic hepatitis.AH): Individual data analysis of the last three randomized placebo controlled double-blind trials of corticosteroids in severe AH. J Hepat 2002;36:547–8.CrossRefGoogle ScholarPubMed
Mathurin, P, Duchatelle, V, Ramond, MJ, Degott, C, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847–55.CrossRefGoogle ScholarPubMed
Schicting, D, Juhl, E, Poulsen, H, Winkel, P, and ,the Copenhagen Study Group for Liver Diseases. Alcoholic hepatitis superimposed on cirrhosis, clinical significance of long term prednisolone treatment. Scan J Gastroenterol 1976;22:305–12.Google Scholar
O'Keefe, C, McCormick, PA. Severe acute alcoholic hepatitis: an audit of medical treatment. Med J 2002;95:108–111.Google Scholar
McCullough, AJ, O'Connor, JFB. Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022–36.CrossRefGoogle ScholarPubMed
Jimenez, JL, Punzon, C, Navarro, J, Munoz-Fernandez, MA, Fresno, M. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor KB and nuclear factor of activated T cells activation. J Pharmacol Exp Ther 2001;299:753–59.Google Scholar
Sanchez, S, Albornoz, L, Bandi, JC, Gerona, S, Mastai, R. Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis. Eur J Gastroenterol Hepatol 1997;9:27–31.CrossRefGoogle Scholar
Akriviadis, E, Botla, R, Briggs, W, Han, S, Reynolds, T, Shakil, O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1787–91.CrossRefGoogle ScholarPubMed
Spahr, L, Rubbia-Brandt, L, Frossard, JL, Giostra, E, et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 2002;37:448–55.CrossRefGoogle ScholarPubMed
Tilg, H, Jalan, R, Kaser, A, Davies, NA, Offner, FA, Hodges, SJ, Ludwiczek, O, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003;38:518–20.CrossRefGoogle ScholarPubMed
Naveau, S, Chollet-Martin, S, Dharancy, S, Mathurin, P, Jouet, P, Piquet, MA, et al. ,Foie-Alcool group of the Association Française pour l'Etude du Foie. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39:1488–90.CrossRefGoogle ScholarPubMed
Poynard, T, Thabut, D, Chryssostalis, A, Taieb, J, Ratziu, V. Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?J Hepatol 2004;38:419–25.Google Scholar
Mookerjee, RP, Tilg, H, Williams, R, Jalan, R. Infliximab and alcoholic hepatitis. Hepatology 2004;40:499–500.CrossRefGoogle ScholarPubMed
McClain, CJ, Hill, DB, Barve, SS. Infliximab and prednisolone: Too much of a good thing?Hepatology 2004;39:1488–90.CrossRefGoogle Scholar
Menon, KV, Stadheim, L, Kamath, PS, Wiesner, RH, et al. A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol 2004;99:255–60.CrossRefGoogle ScholarPubMed
Akerman, PA, Cote, PM, Yang, SG, McClain, C, et al. Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor alpha. Hepatology 1993;17:1066–73.CrossRefGoogle ScholarPubMed
Mezey, E, Potter, JJ. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004:40:40–6.CrossRefGoogle ScholarPubMed
Maza, MP, Peterman, M, Bunout, D, Hirsh, S. Effects of long-term vitamin supplementation in alcoholic cirrhotics. J Am Coll Nutri 1995;14:192–6.CrossRefGoogle ScholarPubMed
Wenzel, G, Kuklinski, B, Ruhlmann, C, Ehrhardt, D. Alcohol-induced toxic hepatitis—a “ free radical ” associates disease. Lowering facility by adjuvant antioxidant therapy. Z Gesamte In Med 1993;48:490–6.Google Scholar
Mato, JM, Camara, J, Fernandez, Pas J, Caballeria, L, Coll, S, Caballero, A, et al. S-adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicenter clinical trial. Hepatol 1999;30:1081–9.CrossRefGoogle ScholarPubMed
Rambaldi, A, Gluud, C. S-Adenosyl-L-methionine for alcoholic liver diseases. Cochrane Database Syst Rev 2004:3Google Scholar
Purohit, V, Russo, D. S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium. Alcohol 2002;27:151–4.CrossRefGoogle ScholarPubMed
Austin, AS, Mahida, YR, Clark, D, Ryder, SD, Freeman, JG. A pilot study to investigate the use of oxypentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis. Aliment Pharmacol Ther 2004;19:78–82.CrossRefGoogle Scholar
Yokota, T, Oritani, K, Takahashi, I, Ishikawa, J, Maatsuyama, A, Ouchi, N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723–32.Google ScholarPubMed
Li, Z, Yang, S, Lin, H, Huang, J, Watkins, PA, et al. Probiotics and antibiotics to TNF inhibit inflammatory activity and improve non-alcoholic fatty liver disease. Hepatology 2003;37:347–50.CrossRefGoogle Scholar
Natori, S, Rust, C, Stadheim, LM, Srinivasan, A, Burgart, LJ, Gores, CJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:330–3.CrossRefGoogle ScholarPubMed
Day, CP. Apoptosis in alcoholic hepatitis: A novel therapeutic target?J Hepatol 2001;34:248–53.CrossRefGoogle ScholarPubMed
Mutimer, DJ, Burra, P, Neuberger, JM, Hubscher, S, Byuckels, JA, et al. Managing severe alcoholic hepatitis complicated by renal failureQ J Med 1993;86:649–56.CrossRefGoogle ScholarPubMed
Jalan, R, Sen, S, Steiner, C, Kapoor, D, Alisa, A, Williams, R. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003;38:104–6.CrossRefGoogle ScholarPubMed
Mendenhall, CL, Anderson, S, Weesner, RE, Goldberg, SJ, Crolic, KA. ,Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis. Am J Med 1984;76:211–22.CrossRefGoogle Scholar
Nompleggi, DJ, Bonkovsky, HL. Nutritional supplementation in chronic liver disease: an analytical review. Hepatology 1994;19:518–33.CrossRefGoogle Scholar
Lochs, H, Plauth, M. Liver cirrhosis: rationale and modalities for nutritional support—the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutri Metab Care 1999;2:345–9.CrossRefGoogle ScholarPubMed
McCullough, AJ, Bugianesi, E. Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol 1997;92:734–8.Google ScholarPubMed
Rambaldi, A, Gluud, C, Rambaldi, A. Propylthiouracil for alcoholic liver disease. Cochrane Database Syst Rev 2005;(4):CD002800.Google Scholar
Rambaldi, A, Gluud, . S-adenosyl-L-methionine for alcoholic liver diseases. Cochrane Review Cochrane Database Syst Rev 2001;4:CD002235.CrossRefGoogle Scholar
Rambaldi, A, Gluud, C. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2005;(2):CD002148.Google Scholar
Rambaldi, A, Iaguinto, G, Gluud, C. Anabolic-androgenic steroids for alcoholic liver disease. CochraneDatabase Syst Rev 2003;(1):CD003045.Google Scholar
Safdar, K, Schiff, ER. Alcohol and hepatitis C. Semin Liver Dis 2004;24:305–15.CrossRefGoogle ScholarPubMed
Mackie, J, Groves, K, Hoyle, A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, risk factors predisposing to recidivism. Liver Transplant 2001;7:418–27.CrossRefGoogle ScholarPubMed
Burro, P, Lucy, MR. Liver transplantation in alcoholic patients. Transpl Int 2005;18:491–8.CrossRefGoogle Scholar
Bellamy, CO, DiMartini, AM, Ruppert, K, et al. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation 2001;72:619–26.CrossRefGoogle ScholarPubMed
Gish, RG, Lee, A, Brooks, L, et al. Long-term follow-up of patients diagnosed with alcohol dependence or alcohol abuse who were evaluated for liver transplantation. Liver Transpl 2001;7:581–7.CrossRefGoogle ScholarPubMed
Stefanini, GF, Biselli, M, Grazi, GL, et al. Orthotopic liver transplantation for alcoholic liver disease: rates of survival, complications and relapse. Hepatogastroenterology 1997;44:1356–9.Google ScholarPubMed
Zibari, GGB, Edwin, D, Wall, L, et al. Liver transplantation for alcoholic liver disease. Clin Transplant 1996;10(6 Pt 2):676–9.Google Scholar
Howard, L, Fahy, T. Liver transplantation for alcoholic liver disease. Br J Psychiatry 1997;171:497–500.CrossRefGoogle ScholarPubMed
Lucey, MR, Brown, KA, Everson, GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997;3:628–37.CrossRefGoogle ScholarPubMed
Osorio, RW, Ascher, NL, Avery, M, et al. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20(1 Pt 1):105–10.Google Scholar
Pageaux, GP, Michel, J, Coste, V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut 1999;45:421–6.CrossRefGoogle ScholarPubMed
Goldar-Najafi, A, Gordon, FD, Lewis, WD, et al. Liver transplantation for alcoholic liver disease with or without hepatitis C. Int J Surg Pathol 2002;10:115–22.CrossRefGoogle ScholarPubMed
Jain, A, DiMartini, A, Kashyap, R, et al. Long-term follow-up after liver transplantation for alcoholic liver disease under tacroimus. Transplantation 2000;70:1335–42.CrossRefGoogle Scholar
Pereira, SP, Williams, R. Alcohol relapse and functional outcome after liver transplantation for alcoholic liver disease. Liver Transpl 2001;7:204–5.CrossRefGoogle ScholarPubMed
Dhar, S.Omran, L, Bacon, BR, et al. Liver transplantation in patients with chronic hepatitis C and alcoholism. Dig Dis Sci 1999;44:2003–7.CrossRefGoogle ScholarPubMed
Tang, H, Boulton, R, Gunson, B, et al. Patterns of alcohol consumption after liver transplantation. Gut 1998;43:140–5.CrossRefGoogle ScholarPubMed
Fabrega, E, Crespo, J, Casafont, F, et al. Alcoholic recidivism after liver transplantation for alcoholic cirrhosis. J Clin Gastroenterol 1998;26:204–6.CrossRefGoogle ScholarPubMed
Kumar, S, Stauber, RE, Gavaler, JS, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990;11:159–64.CrossRefGoogle ScholarPubMed
Bird, GL, O'Grady, JG, Harvey, FA, et al. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990;301:15–17.CrossRefGoogle ScholarPubMed
Knechtle, SJ, Fleming, MF, Barry, KL, et al. Liver transplantation for alcoholic liver disease. Surgery 1992;112:694–701.Google ScholarPubMed
Platz, KP, Mueller, AR, Spree, E, et al. Liver transplantation for alcoholic cirrhosis. Transpl Int 2000:13(Suppl 1):S127–30.CrossRefGoogle Scholar
Gerhardt, TC, Goldstein, RM, Urschel, HC, et al. Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation 1996;62:1060–3.CrossRefGoogle ScholarPubMed
Berlakovich, GA, Steininger, R, Herbst, F, et al. Efficacy of liver transplantation for alcoholic cirrhosis with respect to recidivism and compliance. Transplantation 1994;58:560–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×